截至8月7日收盘，仿制药一致性评价概念下跌1.34%，位居概念板块跌幅榜前列，板块内，千红制药跌 停，华海药业、亚太药业、联环药业等跌幅居前，股价上涨的有18只，涨幅居前的有润都股份、海辰药 业、*ST苏吴等，分别上涨9.98%、7.22%、4.63%。 今日涨跌幅居前的概念板块 | 概念 | 今日涨跌幅（%） | 概念 | 今日涨跌幅（%） | | --- | --- | --- | --- | | 稀土永磁 | 3.24 | 减肥药 | -1.70 | | 脑机接口 | 2.69 | CRO概念 | -1.66 | | 高压氧舱 | 2.56 | 创新药 | -1.41 | | 太赫兹 | 1.65 | 仿制药一致性评价 | -1.34 | | 血氧仪 | 1.62 | 重组蛋白 | -1.29 | | 存储芯片 | 1.40 | 中船系 | -1.28 | | MCU芯片 | 1.18 | 阿尔茨海默概念 | -1.18 | | 无线耳机 | 1.08 | 特钢概念 | -1.02 | | 汽车芯片 | 1.02 | 细胞免疫治疗 | -1.02 | | DRG/DIP | 1.00 | PET铜箔 | ...

证券时报·数据宝统计显示，8月5日机构专用席位现身26只个股龙虎榜，合计净买入1.18亿元。为连续第 4日净买入。个股来看，净买入12只，净卖出14只。 8月5日沪指上涨0.96%，盘后龙虎榜数据显示，机构现身26只个股龙虎榜，净买入12只，净卖出14只。 深沪股通席位出现在14只个股龙虎榜。 新瀚新材，今日收盘涨停，全天换手率为34.85%，成交额为13.38亿元。因日收盘价涨幅达20.00%上榜 龙虎榜，前五大买卖营业部中有4家机构专用席位，为买一、买四、买五、卖四，合计净买入8480.39万 元。资金流向方面，该股全天资金净流入1.42亿元。 北方长龙，今日收盘上涨14.64%，全天换手率为67.52%，成交额为20.15亿元。因日换手率达67.52%上 榜龙虎榜，前五大买卖营业部中有5家机构专用席位，为买一、买二、买四、卖三、卖五，合计净买入 5200.10万元。资金流向方面，该股全天资金净流出6789.44万元。 从市场表现看，机构净买入个股今日平均上涨11.97%，涨幅强于沪指。东杰智能、新瀚新材等表现强 势，股价以涨停报收。通过对近一个月机构净买入个股进行回测发现，机构净买入个股次日上涨概率为 ...

Summary of Key Points Core Viewpoint - On August 5th, a total of 34 stocks were involved with institutional investors, with 18 showing net buying and 16 showing net selling [1] Institutional Buying - The top three stocks with the highest net buying by institutions were: - Dongjie Intelligent: Net buying amount of 209 million [1] - Xinhang New Materials: Net buying amount of 84.8 million [1] - Gongchuang Turf: Net buying amount of 63.12 million [1] Institutional Selling - The top three stocks with the highest net selling by institutions were: - Anglikang: Net outflow amount of 116 million [1] - Chenxin Pharmaceutical: Net outflow amount of 74.22 million [1] - Shanhe Intelligent: Net outflow amount of 51.28 million [1]

Group 1 - The core point of the article is that Anglikon (002940.SZ) experienced a significant decline of 9.46% in its stock price, with a trading volume of 10.94 billion yuan and a turnover rate of 9.9% [1] - Institutional investors sold a net amount of 116 million yuan, while retail investors, represented by "N Tuesday," made a net purchase of 16.42 million yuan [1] - The top five buying institutions accounted for 7.20% of the total trading volume, while the top five selling institutions accounted for 16.81% [1] Group 2 - The largest buying institution was CITIC Securities, which purchased 164.23 million yuan, representing 1.50% of the total trading volume [1] - The largest selling institution was an unnamed institutional investor, which sold 5.93 billion yuan, accounting for 5.42% of the total trading volume [1] - The overall net amount from the top five buying and selling institutions combined was a negative 1.05 billion yuan [1]

| | 机构专用 | | 1486次 43.27% | 763.32 | 0.70% | | --- | --- | --- | --- | --- | --- | | 2 | 机构专用 | | 1486次 43.27% | 1223.45 | 1.12% | | 3 | 国金证券股份有限公司深圳分公司 | | 299次 41.47% | 91.39 | 0.08% | | | 机构专用 | | 1486次 43.27% | 95.16 | 0.09% | | 5 | 机构专用 | | 1486次 43.27% | 0.00 | 0.00% | | | | (买入前5名与卖出前5名)总合计: | | 7871.85 | 7.20% | | 买入金额最大的前5名 | | | | | | | --- | --- | --- | --- | --- | --- | | 序号 | 交易营业部名称 | | | 买入金额(万) | 占总成交比例 | | 1 | 中信证券股份有限公司杭州凤起路证券营业部 | 40次 30.00% | 0 | 1643.46 | 1.50% | | 2 | 国信证券股份有限公司浙江互联网分公 ...

深交所公开信息显示，当日该股因日跌幅偏离值达-10.23%上榜，机构专用席位净卖出1.16亿元。 昂利康今日下跌9.46%，全天换手率9.90%，成交额10.94亿元，振幅7.50%。龙虎榜数据显示，机构净卖 出1.16亿元，营业部席位合计净买入1061.60万元。 证券时报·数据宝统计显示，上榜的前五大买卖营业部合计成交2.63亿元，其中，买入成交额为7871.85 万元，卖出成交额为1.84亿元，合计净卖出1.05亿元。 具体来看，今日上榜的营业部中，共有4家机构专用席位现身，即买四、卖一、卖二、卖四、卖五，合 计买入金额2081.92万元，卖出金额1.37亿元，合计净卖出1.16亿元。 近半年该股累计上榜龙虎榜12次，上榜次日股价平均涨2.61%，上榜后5日平均涨3.74%。 昂利康8月5日交易公开信息 | 买/ 卖 | 会员营业部名称 | 买入金额（万元） | 卖出金额（万元） | | --- | --- | --- | --- | | 买一 | 中信证券股份有限公司杭州凤起路证券营业部 | 1643.46 | 1.17 | | 买二 | 国信证券股份有限公司浙江互联网分公司 | 1526.36 | ...

Group 1 - The Helicobacter pylori concept sector declined by 0.50%, ranking among the top declines in concept sectors, with notable declines in stocks such as Keta Bio, Anglikang, and Asia-Pacific Pharmaceutical [1][2] - Among the 49 stocks in the Helicobacter pylori concept sector, 27 stocks saw price increases, with Zhongheng Group, Hanyu Pharmaceutical, and *ST Sansheng leading the gains at 9.85%, 5.63%, and 5.05% respectively [1][4] - The Helicobacter pylori concept sector experienced a net outflow of 1.725 billion yuan in main funds, with Hanyu Pharmaceutical seeing the largest outflow of 909.33 million yuan [2][3] Group 2 - The top gainers in the concept sectors included the Armament Reorganization concept at 6.12%, PEEK materials at 4.11%, and Brain-Computer Interface at 2.72% [2] - The main funds saw inflows in stocks such as Zhongheng Group, Baicheng Pharmaceutical, and Asia Treasure Pharmaceutical, with inflows of 88.23 million yuan, 63.86 million yuan, and 19.51 million yuan respectively [2][4] - The stocks with the largest net outflows in the Helicobacter pylori concept included Asia-Pacific Pharmaceutical at -8.16%, Keta Bio at -10.28%, and Anglikang at -9.46% [2][3]

Market Overview - A-shares regained the 3600-point mark, with the Shanghai Composite Index rising by 0.53% to 3602.13 points, while the Shenzhen Component increased by 0.14% and the ChiNext Index fell by 0.26% [1][2] Trading Volume - The trading volume in the Shanghai and Shenzhen markets exceeded 1 trillion yuan, reaching 10057 billion yuan, an increase of 849 billion yuan compared to the previous trading day [2] Sector Performance - The military industry sector saw significant activity, with several stocks hitting the daily limit. The PEEK materials sector experienced a surge, and the gaming sector has risen for three consecutive days [2][4][7] Military Sector Highlights - Notable stocks in the military sector included Aerospace Intelligent Equipment, which hit a 20% limit up, and Great Wall Military Industry, which also reached a 10% limit up. The cumulative increase for Great Wall Military Industry since June 18, 2025, is 181.58% [4][5] - The military sector is supported by a continuous increase in global military spending, with China's military manufacturing competitive advantage being underestimated [6] Gaming Sector Highlights - The gaming sector is experiencing a new growth wave, driven by AI technology and the summer season. Stocks like Perfect World and Giant Network saw significant increases [7][8] PEEK Materials Sector - The PEEK materials sector saw a rise, with Huami New Materials on the Beijing Stock Exchange increasing by over 20%. Other companies like Xinhan New Materials and Zhongxin Fluorine Materials also hit the daily limit [9] Steel Sector Performance - The steel sector continued to strengthen, with Maanshan Iron & Steel hitting a 10% limit up. Other companies like Baotou Steel and Fangda Special Steel also saw gains [9][10] Pharmaceutical Sector - The innovative drug sector experienced a pullback after a previous surge, with several stocks in traditional Chinese medicine showing significant declines [11]

Market Performance - The three major A-share indices showed mixed results, with the Shanghai Composite Index up by 0.53%, the Shenzhen Component Index up by 0.14%, and the ChiNext Index down by 0.26% [2] - The North China 50 Index increased by 0.18%, and the total trading volume in the Shanghai and Shenzhen markets reached 101.86 billion yuan, an increase of 8.6 billion yuan compared to the previous day [2] - Over 3,300 stocks in the market experienced gains [2] Sector Performance - The PEEK materials sector, military equipment restructuring, and photolithography machine sectors saw significant gains, while the pharmaceutical sector underwent adjustments [2] - PEEK materials showed strong performance across the board, with Zhongxin Fluorine Materials hitting the daily limit, and companies like Xinhan New Materials, Huami New Materials, and Nanjing Julong rising over 10% [2] - The military equipment restructuring concept experienced fluctuations, with Great Wall Military Industry reaching the daily limit [2] - The photolithography machine sector also performed well, with Zhangjiang Hi-Tech hitting the daily limit [2] - The pharmaceutical sector faced collective adjustments, with Qizheng Tibetan Medicine hitting the daily limit down, and companies like Anglikang and Nanjing New Medicine dropping over 9% [2]

Group 1 - The stock of Aonlikang is approaching a limit down, indicating significant selling pressure [1] - Several pharmaceutical companies, including Nanjing New Pharmaceutical, Huason Pharmaceutical, Yuekang Pharmaceutical, Chenxin Pharmaceutical, Guizhou Bailing, and Shutaishen, have all experienced declines exceeding 6% [1]